Clinical Trials · NCT01280188

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

CompletedPhase 3Desmopressin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Ferring Pharmaceuticals
Enrollment
20
Start date
Jan 2011
Locations
5 sites, Japan
Primary endpoint
Change from Baseline in 24-hour Urine Volume
View Desmopressin compound reference